Recent Advancements of Monotherapy, Combination, and Sequential Treatment of EGFR/ALK-TKIs and ICIs in Non–Small Cell Lung Cancer

Lung cancer is the leading cause of cancer-related deaths with high morbidity and mortality. Non–small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for 85% of all cases. Fortunately, the development of molecular oncology provides a promising and effective therapeutic s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Dehua, Yu, Lun, Shangguan, Dangang, Zhang, Yongchang, Xiao, Bowen, Liu, Ni, Yang, Nong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207473/
https://www.ncbi.nlm.nih.gov/pubmed/35734411
http://dx.doi.org/10.3389/fphar.2022.905947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207473/
https://www.ncbi.nlm.nih.gov/pubmed/35734411
http://dx.doi.org/10.3389/fphar.2022.905947

Ejemplares similares